维普中文期刊产品整合服务
54篇 您的检索式:作者名="Boger R S"
    题名 作者 年代 出处 被引量
1Asymmetric dimethylarginine,derangements of the endothelial nitric oxide synthase pathway,and cardiovascular diseases显示文摘Boger R H Bode-Boger S M 2000Semin Thromb Hemost2000,26,5:1
2A preconditioned Navier-Stokes method for two-phase flows with application to cavitation prediction显示文摘KUNZ R F BOGER D A STINEBRING D R CHYCZEWSKI T S 2000Comput Fluids2000,29,:1
3Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells显示文摘Benndorf R Boger RH Ergiin S 2003Cite Res2003,93,5:1
4Asymmetricdimethylarginie plasma concentrations differ in patients with end-stage renal disease:relation to treatment method and atherosclerotic disease显示文摘Kielstein J T Boger R H Bode-Boger S M 1999J Am Soc Nephrol1999,,6:1
5A simple,high-resolution method for establishing DNA binding affinity and secuence selectivity显示文摘BOGER D L FINK B E BRUNETTE S R et a 0,,:1
6A Simple, High-Resolution Method for Establishing DNA Binding Affinity and Sequence Selectivity显示文摘Boger D L Fink B E Brunette S R 2001J Am Chem Soc2001,123,25:1
7Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renaldisease显示文摘KIELSTEIN J T BOGER R H BODE-BOGER S M etal 2002J Am Soc Nephrol2002,13,:1
8A simple,high-resolution method for establishing DNA binding affinity and sequence selectivity显示文摘Boger D L Fink B E Brunette S R 2001J Am Chem Soc2001,123,:1
9Asymmetric dimethylarginine,derangements of the endothelial nitric oxide synthase pathway,and cardiovascular diseases显示文摘Boger R H Bode-Boger S M 2000Semin Thromb Hemost2000,26,5:1
10An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes显示文摘Boger R H Bode-Boger S M TSAO P S 2000J Am Coll Cardiol2000,36,7:1
11Hardening evolution of AZ31B Mg Sheet显示文摘LOU X Y LI M BOGER R K AGNEW S R WAGONER R H 2007International Journal of Plasticity2007,23,1:1
12Asymmetric dimethylarginine(ADMA):a noval risk factor for endothelialdys function-its role in hypercholesterolemia显示文摘BOGER R H BODE-BOGER S M Szuba A 1998Circulation1998,98,:1
13Hardening evolution of AZ31B Mg sheet显示文摘LOUXY Li M BOGER R AGNEW S WAGONER R 2007International Journal of Plasticity2007,23,1:1
14Asymmetric dimethylarginine (ADMA):a novel risk factor for endothelial dysfunction:its role in hypercholesterolemia显示文摘Boger R H Bode-Boger S M Szuba A 1998Circulation1998,98,18:1
15Plasma concentration of asymmetric dimethylarginine,an endogenous inhibitor of nitric oxide synthase,is elevated in monkeys with hyperhomocyst (e) inemia or hypercholesterolemia显示文摘Boger R H Bode-Boger S M Sydow K 2000Arterioscler Thromb Vasc Biol2000,20,6:1
16Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans显示文摘Chan J R Boger R H Bode-Boger S M 2000Arterioscler Thromb Vasc Biol2000,20,4:1
17General pole num- ber model of the brushless doubly -fed machine 显示文摘BOGER M S WALLACE A K SPEE R 1995IEEE Trans- actions on Industry Applications1995,31,5:1
18Prognosis of patients undergoing ear diae surgery and treated with intra-aortie balloon pump eoun terpulsation prior to surgery:a long term follow up study显示文摘den Uil C A Valk S D Cheng J M Kappetein A P Bogers A J van Domburg R T 2009Interact Cardiovase Thorae Surg2009,9,:1
19The L-ar- ginine-nitrie oxide pathway: role in atherosclerosis and therapeutic implieations 显示文摘Boger R H Bode-boger S M Frolich J C 1996Atherosclerosis1996,127,1:1
20Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst (e) inaemia in humans显示文摘BOGER R H LENTZ S R BODE-BOGER S M 2001Clin Sei (Lond)2001,100,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费